Total support from basic research to clinical development! We provide oligonucleotides with optimal specifications.
At Ajinomoto Bio-Pharma Services Gene Design, we provide a variety of nucleic acid drug seeds such as siRNA, aptamers, antisense, decoys, miRNA, and CpG-ODN, tailored to optimal specifications for cell assays, in vivo experiments, in vitro diagnostic pharmaceuticals, and clinical trial GMP-compliant products. We also offer fluorescent labeling, such as Alexa modifications, and detection probes like LNA oligos at reasonable prices to support your basic research. 【Features】 - Extensive experience with cross-linked nucleic acids such as LNA and BNA, various modifications like 2’-OMe RNA and 2’-F RNA, and peptide, PEG, and ligand terminal additions. - Process development and analytical method development with an eye toward scale-up. - Experience in examining and validating standard testing methods. - Conducting stability tests necessary for GLP studies and clinical development. For more details, please contact us or download the catalog.
Inquire About This Product
basic information
【Now on Sale】 [Long RNA] ○ Supports the synthesis of long-chain RNA → Synthesis and mass confirmation of 150mer RNA → Non-coding RNA, pre-miRNA, sgRNA ○ Design and synthesis of siRNA ○ Synthesis of modified RNA including special bases, terminal labeling, and various modifications [Conjugation] ○ Extensive experience in compound conjugation → PEG, Peptide, Cholesterol, Tocopherol, ligand, Lipid, etc. ○ Supports various conjugation methods → Amide bonds, SS bonds, maleimide-thiol reactions, click reactions, etc. [BNA] ○ Third-generation cross-linked modified nucleic acids → Higher hybridization ability and nuclease resistance than LNA [Other Products] ○ Novel miRNA inhibitor S-TuD (Stud) ○ ECHO probe that emits fluorescence only when hybridized ● For more details, please contact us or download the catalog.
Price information
Please contact us.
Delivery Time
Applications/Examples of results
For more details, please contact us or download the catalog.
Company information
Ajinomoto Bio-Pharma Services and GeneDesign, Inc. are engaged in the production of oligonucleotides, incorporating the latest technologies and patent licenses from various research institutions. We supply distinctive nucleic acid materials, including the introduction of artificially modified nucleic acids and the addition of functional molecules, contributing to the development of new technologies in the gene-related fields (such as drug development, diagnostic technology development, and bio-research technology development). Currently, the demand for various synthetic nucleic acids is expanding from cell culture levels to animal testing and further to clinical trials. Our company has established a system capable of supplying everything from research reagents to investigational drugs at all scales, and we are advancing research and development daily as a company that can significantly contribute to the creation of nucleic acid pharmaceuticals and the practical application of diagnostic systems. For the future of medicine, we aim to be a company that contributes to the welfare and health of people through the development of nucleic acid manufacturing technologies, actively working on the development of next-generation nucleic acid drugs and diagnostic materials.
